Crow Point Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	$206K	Buy	+1,800	New	+$206K	0.32%	60
2019 Q2	–	Sell	-2,190	Closed	-$205K	–	120
2019 Q1	$205K	Buy	+2,190	New	+$205K	0.03%	111